CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
176 hedge funds and large institutions have $2.76B invested in Clovis Oncology, Inc. in 2015 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 58 increasing their positions, 55 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
5% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 55
6% less call options, than puts
Call options by funds: $42.9M | Put options by funds: $45.9M
Holders
176
Holding in Top 10
13
Calls
$42.9M
Puts
$45.9M
Top Buyers
| 1 | +$39.3M | |
| 2 | +$26.6M | |
| 3 | +$26.3M | |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$24.5M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$21.4M |
Top Sellers
| 1 | -$100M | |
| 2 | -$46.5M | |
| 3 | -$35.8M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$18M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$17.7M |